SILVEC BIOLOGICS, INC.

Latest events

• Sep 2023Federal grantNSF · Phase II · SBIR Phase II: Using a novel RNA therapy to immunize trees and vines against deadly bacteria$995K
• Sep 2023Federal grantAgriculture · **awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** Plant Fungal Diseases Present An Ongoing And Significant Threat To Global Agriculture, Causing Approximately 10% Of Annual Crop Losses Worldwide. These Diseases Not Only Result In Substantial Economic Losses Exceeding $200 Billion Annually But Also Raise Concerns Regarding The Environmental And Health Impacts Associated With Fungic$650K
• May 2022Federal grantAgriculture · Trees, Vines, And Bushes Are Plagued By Pathogens Causing Over $100B In Annual Damage. Fungi Are Of Particular Concern, Causing 85% Of Pathogen-related Crop Losses. For Certain Especially Damaging Fungi Like Boytrytis Cinerea, There Are No Varieties With Natural Resistance In Its Host Range. As B. Cinerea Is Estimated To Cause Over $10B In Annual Damage, There Is A Strong Driver For Effective Control Solutions, Especially Ones More Environmentally Friendly Than Conventional Chemical Fungicides. $175K
• Jun 2021Offering registeredForm D · SEC · 2nd filing$150K
• Feb 2021Federal grantNSF · Phase I · SBIR Phase I: Using a novel RNA therapy to immunize trees and vines against deadly bacteria$256K
• Dec 2020Offering registeredForm D · SEC · 1st filing$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.